Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria - PubMed (original) (raw)

. 2011 Feb;69(2):292-302.

doi: 10.1002/ana.22366.

Stephen C Reingold, Brenda Banwell, Michel Clanet, Jeffrey A Cohen, Massimo Filippi, Kazuo Fujihara, Eva Havrdova, Michael Hutchinson, Ludwig Kappos, Fred D Lublin, Xavier Montalban, Paul O'Connor, Magnhild Sandberg-Wollheim, Alan J Thompson, Emmanuelle Waubant, Brian Weinshenker, Jerry S Wolinsky

Affiliations

• PMID: 21387374
• PMCID: PMC3084507
• DOI: 10.1002/ana.22366

Free PMC article

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

Chris H Polman et al. Ann Neurol. 2011 Feb.

Free PMC article

Abstract

New evidence and consensus has led to further revision of the McDonald Criteria for diagnosis of multiple sclerosis. The use of imaging for demonstration of dissemination of central nervous system lesions in space and time has been simplified, and in some circumstances dissemination in space and time can be established by a single scan. These revisions simplify the Criteria, preserve their diagnostic sensitivity and specificity, address their applicability across populations, and may allow earlier diagnosis and more uniform and widespread use.

Copyright © 2011 American Neurological Association.

PubMed Disclaimer

Comment in

• Diagnostic criteria in multiple sclerosis: headed in the right direction but still a ways to go.
  Rudick RA. Rudick RA. Ann Neurol. 2011 Feb;69(2):234-6. doi: 10.1002/ana.22388. Ann Neurol. 2011. PMID: 21387367 No abstract available.
• Multiple sclerosis II: new diagnostic criteria, association with smoking and effects of cannabis on cognitive function.
  Strupp M. Strupp M. J Neurol. 2011 May;258(5):954-7. doi: 10.1007/s00415-011-6049-2. J Neurol. 2011. PMID: 21512740 No abstract available.
• 2010 revisions to McDonald criteria for diagnosis of multiple sclerosis: impact of 3-Tesla magnetic resonance imaging.
  Kilsdonk ID, Barkhof F, Wattjes MP. Kilsdonk ID, et al. Ann Neurol. 2011 Jul;70(1):182-3. doi: 10.1002/ana.22490. Epub 2011 Jun 27. Ann Neurol. 2011. PMID: 21710623 No abstract available.
• Revised McDonald criteria: the persisting importance of cerebrospinal fluid analysis.
  Tumani H, Deisenhammer F, Giovannoni G, Gold R, Hartung HP, Hemmer B, Hohlfeld R, Otto M, Stangel M, Wildemann B, Zettl UK. Tumani H, et al. Ann Neurol. 2011 Sep;70(3):520; author reply 521. doi: 10.1002/ana.22508. Epub 2011 Jun 27. Ann Neurol. 2011. PMID: 21710627 No abstract available.
• Cerebrospinal fluid analysis in the 2010 revised McDonald's multiple sclerosis diagnostic criteria.
  Galea I, Freedman MS, Thompson EJ. Galea I, et al. Ann Neurol. 2011 Jul;70(1):183; author reply 183-4. doi: 10.1002/ana.22466. Ann Neurol. 2011. PMID: 21786311 No abstract available.

Similar articles

• Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria".
  Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, Lublin FD, Metz LM, McFarland HF, O'Connor PW, Sandberg-Wollheim M, Thompson AJ, Weinshenker BG, Wolinsky JS. Polman CH, et al. Ann Neurol. 2005 Dec;58(6):840-6. doi: 10.1002/ana.20703. Ann Neurol. 2005. PMID: 16283615 Review.
• [Diagnosis of multiple sclerosis: A review of the 2017 revisions of the McDonald criteria].
  Csépány T . Csépány T . Ideggyogy Sz. 2018 Sep 30;71(9-10):321-329. doi: 10.18071/isz.71.0321. Ideggyogy Sz. 2018. PMID: 30335264 Review. Hungarian.
• [Diagnosis of multiple sclerosis--the 2010 revision of the McDonald criteria].
  Mathiesen HK, Sørensen PS. Mathiesen HK, et al. Ugeskr Laeger. 2012 Mar 26;174(13):862-5. Ugeskr Laeger. 2012. PMID: 22456173 Danish.
• Diagnosis of multiple sclerosis: revisions of the McDonald criteria 2017 - continuity and change.
  Hartung HP, Graf J, Aktas O, Mares J, Barnett MH. Hartung HP, et al. Curr Opin Neurol. 2019 Jun;32(3):327-337. doi: 10.1097/WCO.0000000000000699. Curr Opin Neurol. 2019. PMID: 30985371 Review.
• Revised diagnostic criteria of multiple sclerosis.
  Milo R, Miller A. Milo R, et al. Autoimmun Rev. 2014 Apr-May;13(4-5):518-24. doi: 10.1016/j.autrev.2014.01.012. Epub 2014 Jan 12. Autoimmun Rev. 2014. PMID: 24424194 Review.

Cited by

• Investigation of multiple sclerosis-related pathways through the integration of genomic and proteomic data.
  Everest E, Ülgen E, Uygunoglu U, Tutuncu M, Saip S, Sezerman OU, Siva A, Tahir Turanli E. Everest E, et al. PeerJ. 2021 Sep 6;9:e11922. doi: 10.7717/peerj.11922. eCollection 2021. PeerJ. 2021. PMID: 39544199 Free PMC article.
• Achievement of No Evidence of Disease Activity-3 with Oral Disease-Modifying Treatment in Patients with Relapsing-Remitting Multiple Sclerosis.
  Alshamrani FJG, Zafar A, Alsawad RM, Yasawy Z, Shahid R, Nazish S, Shariff E, Soltan NM. Alshamrani FJG, et al. Saudi J Med Med Sci. 2024 Oct-Dec;12(4):299-305. doi: 10.4103/sjmms.sjmms_148_24. Epub 2024 Oct 12. Saudi J Med Med Sci. 2024. PMID: 39539793 Free PMC article.
• Obesity Affects Disease Activity and Progression, Cognitive Functioning, and Quality of Life in People With Multiple Sclerosis.
  Wu J, Alfredsson L, Olsson T, Hillert JA, Hedström AK. Wu J, et al. Neurol Neuroimmunol Neuroinflamm. 2025 Jan;12(1):e200334. doi: 10.1212/NXI.0000000000200334. Epub 2024 Nov 13. Neurol Neuroimmunol Neuroinflamm. 2025. PMID: 39536290 Free PMC article.
• Prevalence of comorbid autoimmune diseases and antibodies in newly diagnosed multiple sclerosis patients.
  Jendretzky KF, Lezius LM, Thiele T, Konen FF, Huss A, Heitmann L, Güzeloglu YE, Schwenkenbecher P, Sühs KW, Skuljec J, Wattjes MP, Witte T, Kleinschnitz C, Pul R, Tumani H, Gingele S, Skripuletz T. Jendretzky KF, et al. Neurol Res Pract. 2024 Nov 12;6(1):55. doi: 10.1186/s42466-024-00351-2. Neurol Res Pract. 2024. PMID: 39533435 Free PMC article.
• SCALA: a randomized phase I trial comparing subcutaneous and intravenous alemtuzumab in patients with progressive multiple sclerosis.
  Montalban X, Rodriguez-Acevedo B, Nos C, Resina M, Forner M, Wu Y, Chirieac M. Montalban X, et al. Ther Adv Neurol Disord. 2024 Nov 6;17:17562864241291655. doi: 10.1177/17562864241291655. eCollection 2024. Ther Adv Neurol Disord. 2024. PMID: 39513023 Free PMC article.

References

1. 1. Schumacher FA, Beeve GW, Kibler RF, et al. Problems of experimental trials of therapy in multiple sclerosis. Ann N Y Acad Sci. 1965;122:552–568. - PubMed
2. 1. Poser CM, Paty DW, Scheinberg LC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983;1:227–231. - PubMed
3. 1. Paty DW, Oger JJ, Kastrukoff LF, et al. MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding and CT. Neurology. 1988;38:180–185. - PubMed
4. 1. Barkhof F, Filippi M, Miller DH, et al. Comparison of MR imaging criteria at first presentation to predict conversion to clinically definite MS. Brain. 1997;120:2059–2069. - PubMed
5. 1. Fazekas F, Offenbacher H, Fuchs S, et al. Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis. Neurology. 1988;38:1822–1825. - PubMed

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • Ovid Technologies, Inc.
  • PubMed Central
  • Wiley

• Other Literature Sources

  • H1 Connect
  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information